Femasys

NEWS

Pictured: IVF collage/Nicole Bean for BioSpace

Policy

Alabama Ruling, Political Blowback Rattle In Vitro Fertilization Market

A controversial decision by the Alabama Supreme Court temporarily chilled IVF before igniting nationwide pushes to protect access to this type of fertility treatment, leaving drugmakers with questions.

March 12, 2024

5 min read

Neil Versel

IN THE PRESS

Press Releases

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

November 1, 2024

4 min read

Press Releases

Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed

October 30, 2024

7 min read

Press Releases

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

October 10, 2024

4 min read

Press Releases

Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

October 8, 2024

3 min read

Press Releases

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

October 2, 2024

4 min read

Press Releases

Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market

September 11, 2024

4 min read

Press Releases

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check

September 9, 2024

4 min read

Press Releases

Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting

September 5, 2024

4 min read

Business

Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference

September 3, 2024

3 min read

Press Releases

Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution

August 30, 2024

4 min read

AWARDS

JOBS